Rezolute Inc (RZLT): Total Asset Value of Company

Graphic logo of Rezolute Corp (RZLT)

The asset's price trajectory reflects the total aggregate assets of Rezolute, Inc. (RZLT), which currently stand at 144.17. The business relies on a virtual management model, outsourcing production and testing to third-party contractors. Rezolute, Inc. (RZLT) targets patients with rare endocrine pathologies, relying on insurance reimbursements. Innovative treatments for hyperinsulinism are currently undergoing validation, creating potential for future sales.

Rezolute, Inc. (RZLT) Company Total Assets: for the period 07/04/2022 - 10/29/2026

Comprehensive metric breakdowns and analytics for Rezolute Corp (RZLT)

- price and consensus price forecast:
Price rezolutebio.com|RZLT - Price Target Chart
- market capitalization data:
Market Valuation Rezolute Bio|RZLT - Enterprise Value
- book capitalization data:
Accounting Value of a Share Rezolute|RZLT - Book Capitalization|Market Capitalization to Book Value Ratio rezolutebio.com|RZLT - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Rezolute, Inc.|RZLT - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Rezolute Bio|RZLT - Company Aggregate Debts|Debts to Book Capitalization Rezolute Bio|RZLT - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Rezolute
Fundamental valuation:RZLT, rezolutebio.com
Finished products of Rezolute, Inc.

For investors in Rezolute, Inc. (RZLT), it is critical to track the combination of equity and debt, which is reverse-calculated via return on assets (ROA) to assess the fundamental value of resources. Analyzing the growth of all company resources reveals how an asset-light model utilizing CMO outsourcing minimizes capital expenditures, transforming intellectual property into the primary driver of business value.

Competitors of Rezolute, Inc. (RZLT)

ASND (ascendispharma.com) - Aggregate Business Assets|Aggregate Company Assets Madrigal Pharmaceuticals, Inc. MDGL|Total Asset Value of Company Corcept Therapeutics Inc.|Rhythm Pharmaceuticals Inc (RYTM) - Company Total Assets|Aggregate Asset Value Akero Corp (AKRO)|Company Total Assets MTSR (Metsera Inc)|moonlaketx.com - Company Total Assets|Aggregate Company Assets Crinetics (CRNX)|NAMS: Aggregate Asset Value|SLNO (Soleno) - Aggregate Company Assets|Amicus Corp (FOLD) - Cumulative Company Assets|ETNB (89bio, Inc.) - Company Total Assets|Company Total Assets agios.com (AGIO)|Structure Therapeutics Inc. (GPCR) - Cumulative Company Assets|Aggregate Asset Value MDXG (MiMedx Group Inc)|Lexicon Pharma - Aggregate Company Assets|Cumulative Company Assets MBX Corp MBX|ALT (Altimmune, Inc.) - Company Total Assets|aardvarktherapeutics.com (AARD) - Company Assets|SGMT - Cumulative Company Assets|BioAge Labs (BIOA) - Aggregate Business Assets|BMEA (Biomea) - Company Total Assets|Company Total Assets Quince|Company Total Assets Fractyl Health, Inc. (GUTS)|Aggregate Company Assets VTVT (vtvtherapeutics.com)|ATPC: Aggregate Company Assets|Pluristem Therapeutics - Company Assets|SYBX - Aggregate Company Assets|LPCN - Aggregate Company Assets|matinasbiopharma.com - Company Total Assets|SPRB (sprucebiosciences.com) - Company Total Asset Base|GLTO: Aggregate Company Assets|Company Total Asset Base CTCX|Aggregate Company Assets LUMO (Lumos Pharma Corp)|Cumulative Company Assets ONVO (Organovo Corp)|Aggregate Company Assets Radius Recycling, Inc.